MIRA Pharmaceuticals (MIRA)

• Market cap: $38.8M
• 1 day: 0.49%
• 5 days: -1.65%
• 1 month: -5.68%
• 3 months: -7.23%
• 6 months: -37.53%
• Year to date: -37.95%
• 1 year: -22.96%
• 5 years: -87.54%
• 10 years: -87.54%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Employees: 2